Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

NILOTINIB vs NINTEDANIB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

NILOTINIB vs NINTEDANIB: Safety Overview

Metric NILOTINIB NINTEDANIB
Total FAERS Reports 23,171 26,243
Deaths Reported 4,543 5,822
Death Rate 19.6% 22.2%
Hospitalizations 4,846 9,433
Average Patient Age 56.5 yrs 70.7 yrs
% Female Patients 47.7% 41.8%
FDA Approval Date Dec 15, 2025 N/A
Manufacturer Novadoz Pharmaceuticals LLC N/A
Route ORAL N/A
Marketing Status Prescription None